This webinar was on Sept. 21. Watch the recording now!

About

Learn about the current recommendations surrounding COVID-19 and immunocompromised individuals in this presentation by Dr. Miskulin.

Dana Miskulin, MD

Speaker

Dr. Miskulin is a nephrologist at Tufts Medical Center, Boston MA. She sees patients in the ADPKD Specialty Clinic and serves as an investigator for clinical trials in ADPKD at the Tufts MC site.

Learning objective(s):

  • Understand the implications of the Delta variant of COVID.
  • Learn precautions needed against the Delta variant of COVID.
  • Discuss the current CDC recommendations regarding COVID and immunocompromised individuals.

Related Resources

ARPKD EL-PFDD 2023

ARPKD EL-PFDD 2023

What to Expect from the ARPKD EL-PFDD Meeting On August 29, 2023 the PKD Foundation will hold its first ever Externally Led Patient-focused Drug Development (EL-PFDD) Meeting on Autosomal Recessive PKD (ARPKD) and Congenital Hepatic Fibrosis (CHF). Should you attend the meeting? What should you...

ADPKD Registry Annual Report 2022

ADPKD Registry Annual Report 2022

The PKDF Research team is excited to expand the features available in the ADPKD Registry in summer 2023. This project has been carefully planned and executed with our patients at the center. The last few years have been spent building the largest ADPKD patient-reported outcomes dataset.